VR Logo

Protagonist Therapeutics Inc. (PTGX) download report


Healthcare | Biotechnology & Pharma Research

Protagonist Therapeutics Inc. (PTGX) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases.

IPO Date: 11-Aug-2016

CEO, Pres, Sec. & Director: Dr. Dinesh V. Patel Ph.D.

Chief R&D Strategy Officer: Dr. David Y. Liu Ph.D.

Listing: NASDAQ: PTGX

Country: United States

Headquarters: Newark, CA

Website: https://www.protagonist-inc.com

Key Facts

Market cap: $382.44 Mln

Revenue (TTM): $46.89 Mln

Earnings (TTM): $-122.48 Mln

Cash: $305.29 Mln

Total Debt: $5.34 Mln

Insider's Holding: 1.43%

Liquidity: Low

52 Week range: $6.91 - 50.54

Shares outstanding: 48,656,200

8 Years Aggregate:

  • CFO: $-320.05 Mln
  • EBITDA: $-389.53 Mln
  • Net Profit: $-407.88 Mln

Stock Performance

Time Period Protagonist Therapeutics (PTGX) S&P BSE Sensex* S&P Small-Cap 600*
YTD-77.02-8.62-18.78
1 month-11.69-4.54-8.00
3 months-66.81-10.19-13.65
1 Year-82.491.43-17.19
3 Years-13.4210.146.10
5 Years-7.0211.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Protagonist Therapeutics (PTGX) S&P Small-Cap 600 S&P BSE Sensex
202169.6425.2721.99
2020185.969.5715.75
20194.7520.8614.38
2018-67.44-9.705.87
2017-5.4111.7327.91